As we present these arguments to lawmakers and DoD officials alike, we will advocate for updated federal regulations to preserve the TFL benefit and continue coverage parity for GLP-1 drugs and in future coverage decisions
[DOI] [PubMed] [Google Scholar] 124.Sista F., Abruzzese V., Clementi M., Carandina S., Cecilia M., Amicucci G
Rethinking Risk Thresholds in Diabetes Care May 12, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,113 views A patient loses 30 pounds, lowers their A1C, and improves their blood pressure within months of starting a GLP-1 medication
Some of the severe side effects include: Risk of thyroid cancer Hypoglycemia Gallbladder issues Pancreatitis Allergic reactions Preference for Injectable Semaglutide Many patients prefer the injectable form due to its convenience and less frequent dosing